Delayed Visual Maturation: Outcome and Predictive Factors (DVM)

May 7, 2020 updated by: Universitaire Ziekenhuizen KU Leuven
The objectives of the study are to describe the developmental outcome in a population of children with delayed visual maturation.

Study Overview

Status

Completed

Detailed Description

description of the developmental outcome of children with delayed visual maturation.

Study Type

Observational

Enrollment (Actual)

71

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Leuven, Belgium, 3000
        • Universitaire Ziekenhuizen Leuven

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

3 years to 14 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

patients seen in UZ Leuven between 1998 and 2016 with diagnosis of delayed visual maturation who meet the inclusion criteria.

Description

Inclusion Criteria:

  • Infants (male or female) with suboptimal/absent visual contact at the age of ≥3 months, without other known general developmental delay at the time diagnosis of delayed visual contact and without anatomic ocular abnormalities at the initial ophthalmological examination.

Exclusion Criteria:

  • Children with known underlying psychomotor developmental delay or epilepsy at first ophthalmic consultation.
  • Children with ophthalmic (anatomical) abnormalities that explain delayed visual maturation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
delayed visual maturation
children with delayed visual maturation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
delayed visual maturation.
Time Frame: 1998-2016
the prevalence of developmental problems in children with delayed visual maturation.
1998-2016

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Level of development
Time Frame: 1998-2016
by questionnaire:type of education/school , problems with writing, mathematics: yes or no
1998-2016
Fine and gross motor skills
Time Frame: 1998-2016
by questionnaire: physiotherapy needed yes or no
1998-2016
ophthalmological problems
Time Frame: 1998-2016
by questionnaire : visual problems, wearing glasses? taped eyes?
1998-2016
Visual acuity
Time Frame: 1998-2016
assested at the last consultation indicated in Snellen
1998-2016

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ingele Casteels, PhD, UZ Leuven

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 3, 2019

Primary Completion (Actual)

February 10, 2020

Study Completion (Actual)

February 10, 2020

Study Registration Dates

First Submitted

December 31, 2019

First Submitted That Met QC Criteria

January 30, 2020

First Posted (Actual)

January 31, 2020

Study Record Updates

Last Update Posted (Actual)

May 8, 2020

Last Update Submitted That Met QC Criteria

May 7, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • S62961

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Delayed Visual Maturation

Subscribe